Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer.

ABSTRACT:

SUBMITTER: Ivanidze J 

PROVIDER: S-EPMC8713741 | biostudies-literature | 2021 Jan-Dec

REPOSITORIES: biostudies-literature